Clinical Trials Directory

Trials / Completed

CompletedNCT00523185

A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the efficacy of two commonly used medications in the treatment of alcohol withdrawal, diazepam and lorazepam.

Detailed description

Despite the frequent use of benzodiazepines for the treatment of alcohol withdrawal, studies comparing the efficacy of long and short half-life benzodiazepines in the treatment of alcohol withdrawal have shown mixed results. Due to the conflicting nature of published reports, clinicians have no clear indication as to which type of agent is preferable. The purpose of this study is to compare the efficacy of two commonly accepted medications in the treatment of alcohol withdrawal, diazepam and lorazepam, which are long and short half-life benzodiazepines, respectively.

Conditions

Interventions

TypeNameDescription
DRUGLorazepamLorazepam 1 to 2 mg by mouth or intravenously every two hours as needed for alcohol withdrawal symptoms.
DRUGDiazepamDiazepam 20 mg by mouth every two hours x 3 doses, or for parenteral treatment, diazepam 10 mg intravenously every one hour x 6 doses. Give additional diazepam 10 mg by mouth or intravenously every two hours as needed for alcohol withdrawal symptoms.

Timeline

Start date
2003-05-01
Completion
2004-11-01
First posted
2007-08-31
Last updated
2007-08-31

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00523185. Inclusion in this directory is not an endorsement.